The "Global Mice Model Market by Model Types (Inbred, Outbred, Hybrid), Services (Breeding, Rederivation), Technology (Microinjection, CRISPR/Cas9), Therapeutic Area (Oncology, Neurology, Immunology), Application (Research, Drug Discovery) - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
The mice model market is projected to reach USD 2.2 billion by 2029 from an estimated USD 1.5 billion in 2024, at a CAGR of 8.1% during the forecast period. The growth of this market can be attributed to the research and development efforts aimed at drug discovery and development for novel therapies and employment of mice model in studies, and the growing focus on personalized medicines in oncology.
The model type segment accounted for the largest share by model type & service in 2023
In 2023, the model type segment accounted for the largest share of model type & service segment in the global mice model market. The factors such as the genetic similarity of mice with that of humans, also the mice models play a crucial role in studying human diseases, testing new drugs and therapies, and understanding biological processes are driving the growth of this market.
The Asia-Pacific region is growing at the highest CAGR in the mice model market during the forecast period of 2024-2029
The Asia-Pacific region is expected to grow at the highest growth rate during the forecast period. Various factors including growing adoption of mice model based pre-clinical studies and booming healthcare sector are propelling the growth of mice model market in the region.
Increased funding and investments from pharmaceutical and biotechnology companies to develop novel technologies are expected to propel the growth of the mice model market in the Asia-Pacific region. As the region continues to invest in biomedical research and pharmaceutical development, there is a growing demand for mice models to support preclinical studies and drug discovery efforts. Additionally, the increasing prevalence of chronic diseases in Asia-Pacific countries has fueled the need for reliable animal models to better understand disease mechanisms and test potential therapies.
List of Companies Profiled in the Report:
- Charles River Laboratories (US)
- Inotiv (US)
- THE JACKSON LABORATORY (US)
- GemPharmatech (China)
- Cyanogen (US)
- Shanghai Model Organisms Center, Inc. (China)
- JSR Corporation (Japan)
- Biocytogen (China)
- TRANS GENIC INC. (Japan)
- Ozgene Pty Ltd. (Australia)
- Taconic Biosciences, Inc. (US)
- TransCure bioServices (France)
- Harbour BioMed (China)
- Marshall BioResources (US)
- genOway (France)
- Vivo Bio Tech Ltd. (India)
- ingenious targeting laboratory (US)
- Janvier Labs (France)
- Applied StemCell (US)
- Creative Animodel (US)
- JOINN Laboratories Co., Ltd. (China)
- Creative Biolabs (US)
- Crescendo Biologics (UK)
- Aragen Life Sciences (India)
- PolyGene (Switzerland)
For more information about this report visit https://www.researchandmarkets.com/r/lqd9rf
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240513086274/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
